Prevention, treatment, and antiviral chemotherapy.
D002644:Chickenpox / Q000517:prevention & control; D003561:Cytarabine / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000517:prevention & control; D005260:Female; D005315:Fetal Diseases / Q000628:therapy*; D006509:Hepatitis B / Q000517:prevention & control; D006561:Herpes Simplex / Q000517:prevention & control; D006562:Herpes Zoster / Q000517:prevention & control; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use; D007116:Immunization, Passive; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000628:therapy*; D008297:Male; D011051:Poliomyelitis / Q000517:prevention & control; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D012409:Rubella / Q000517:prevention & control; D012411:Rubella Vaccine / Q000008:administration & dosage; D014165:Transfer Factor; D014611:Vaccination; D014615:Vaccinia / Q000517:prevention & control; D014740:Vidarabine / Q000627:therapeutic use; D014777:Virus Diseases / Q000628:therapy*
D012411:Rubella Vaccine; D014165:Transfer Factor; D003561:Cytarabine; D014740:Vidarabine; D007065:Idoxuridine